Monash University Health Collab Design+ Health and Medical Innovation Symposium

Presented by Monash University Health Collab, the 2019 Design+ Health and Medical Innovation Symposium brought together researchers from different disciplines to spark design collaboration and envision a new future for healthcare. Held on March 12 at the Monash Art Design and Architecture (MADA) Centre in Kunshan China, Cobalt’s designs for the Dermapen 4 and Cylite OCT instrument were featured.

The Monash University Health Collab is an interdisciplinary team of researchers, designers and clinicians who employ a people-centred design approach to understand and provide significant high-impact healthcare. MADA Practice Professors Daphne Flynn and Mark Armstrong, along with Centre Director Ian Wong and Centre Creative Director Bernie Walsh run the symposium as a catalyst for innovation and to celebrate design achievements in the health space.

The 2019 March symposium drew academics and business people from both within and outside the health space, facilitating fresh collaboration and inspiring deeper conversations about the future of health care. In a video presented by Health Collab directors Professor Daphne Flynn and Professor Mark Armstrong, they spoke about the importance of utilising design as vehicle to increase traction for health outcomes, and understanding that design is the common thread connecting us all.

The result of the symposium was a success, enabling academics from all over the world to engage with high tech medical companies in Kunshan and to celebrate outcomes already achieved, including Cobalt’s designs.

Wining a Good Design award in 2018, the Dermapen 4­ sets a new benchmark for improving the effectiveness of treatments and resolving traditional limitations, such as power-cord handling issues, calibration difficulties and potential cross-contamination prevention. The DP4 is also the first micro-needling tool capable of performing scar-treatments. The patent-pending 16 needle cartridge has unparalleled needling depth, allowing practitioners to access the Scar Treatment market, expanding the horizons of their practice’s offering.

Similarly, aimed for use in a variety of clinical settings (including both research laboratories and patient-serving clinics) the Cylite HP-OCT ophthalmic device was designed to integrate a high technology core within an ergonomic, user friendly exterior. The revolutionary ocular imaging and measurement technique overcomes issues of motion artefacts or data error from patient eye movement during OCT imaging, and offers a unique proposition to clinicians with its ability to replace four different instruments. The fully automated volumetric acquisition reduces patient chair time and improves the reliability of the results, eliminating guesswork during analysis and diagnosis.

More News+ articles